Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study
Sarah Pett(MRC Clinical Trials Unit at UCL), Kate Brekke, Shane Hodgson(Minneapolis VA Health Care System), Chris H. Wendt(University of Minnesota), Pablo Herrero(Hospital Universitario Central de Asturias), Timothy J. Griffin(University of Minnesota), Rocío Montejano, André de Moricz, Vicky Gioukari, Sean Emery(Brunel University of London), Barbara Standridge, Olga Anagnostou, Rutger Bennet(Karolinska University Hospital), Peeraporn Kaew-on, Nicholas I. Paton(St George's Hospital), Filippo Pacciarini, Katharina Tillmann, Alejandro Sánchez, Kiat Ruxrungtham(Chulalongkorn University), Waldo Belloso(Hospital Italiano de Buenos Aires), Sasiwimol Ubolyam(HIV Netherlands Australia Thailand Research Collaboration), Fleur Hudson(Royal Free London NHS Foundation Trust), Bitten Aagaard(Rigshospitalet), Richard T. Davey(National Institutes of Health), Giota Touloumi(National and Kapodistrian University of Athens), Dominic E. Dwyer(The University of Sydney), Deborah Wentworth(University of Minnesota), Begoña Portas, Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), M Delfino, Raquel Nahra(Cooper University Hospital), D Courtney-Rogers, Ken M. Kunisaki(University of Minnesota), M. Jimena Sáenz(Centro Científico Tecnológico - Tucumán), Michael J. Vjecha, Richard A. Robson, M Losso(Hospital Ramos Mejía), D. A. Cooper, Sarah Pett(MRC Clinical Trials Unit at UCL), Alberto La Rosa(Asociación Civil Impacta Salud y Educación), Pedro Moreno López, Matt Pearson, Y Collaco Moraes, Ioannis Kalomenidis(Evangelismos Hospital), Fred M. Gordin, Paul Jansson, Brian Angus(University of Oxford)
Cited by 17
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
|The Lancet Psychiatry|2020|1.3k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k